Delivery Order SPE2DB25D3110-SPE2DB25FTECW
- Not listed
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml). This firm fixed-price, competitively awarded contract is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and is...
- The Defense Logistics Agency awarded a $1,878.66 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order is scheduled for completion by August 13, 2025, with performance occurring at...
- The Defense Logistics Agency awarded a $2,007.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The place of performance is listed as AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $1,086.58 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of Trulicity 0.75 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical products will be delivered to the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pen injectors valued at $12,590.49. This non-competitive, firm fixed-price delivery order is expected to be completed by August 19, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,050.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on August 18, 2025, with completion targeted for August 19, 2025. The contract employs firm fixed pricing under a non-competitive delivery order structure and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,204.20 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pen injectors with a completion date of September 5, 2025. This firm fixed-price, non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at approximately $1 billion through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a $5,555.55 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $8,473.05 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pen injectors on August 6, 2025, with completion targeted for August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3110Indefinite Delivery Contract
- SPE2DB25D3110-SPE2DB25FTECWDelivery Order
The Defense Logistics Agency awarded a $2,581.21 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injectors (0.5 ml units). This firm fixed-price contract, with performance completed by August 19, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was competitively awarded with no set-aside designation. Performance will be executed from the company's headquarters in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, leveraging its comprehensive IDC vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The SPE2DX contract functions as a global pharmaceutical support platform enabling the company to serve customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Trulicity, a diabetes management medication, exemplifies the company's ongoing role in supporting federal medical supply chains through the DLA's pharmaceutical procurement operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/18/25 |